Cancer Immunology

Search results

• Mount Sinai cancer researcher receives award for lifetime achievement

  Nina Bhardwaj

  28/06/22

  1 item of Media coverage

  Press/Media

• A Brave New World for Spatial Genomics in Cancer Research

  Brian Brown

  27/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research

  Nina Bhardwaj

  21/06/22 → 23/06/22

  13 items of Media coverage

  Press/Media

• US Indian cancer research body honors Dr.Nina Bhardwaj with prestigious award

  Nina Bhardwaj

  22/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research.

  Nina Bhardwaj

  21/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Researcher Receives Prestigious Award From the..

  Nina Bhardwaj

  21/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Discover Genes That Predict Good Response to Blood Cancer Therapy

  Samir Parekh

  16/06/22 → 17/06/22

  2 items of Media coverage

  Press/Media

• Mount Sinai to Lead Discussions on Transgender Health, Psychedelic Therapeutics and Long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival.

  Marci Bowers, Brian Brown, Thomas Fuchs, Zahi Fayad, Joshua Safer, Rachel Yehuda, Helen Mayberg, & Kenneth L. Davis

  16/06/22

  1 item of Media coverage

  Press/Media

• Redding Resident Craig Lawrence's 16 Years of Making Waves for Cancer

  Brian Brown

  16/06/22

  1 item of Media coverage

  Press/Media

• Redding Resident Craig Lawrence Is...

  Brian Brown

  16/06/22

  1 item of Media coverage

  Press/Media

• Researchers Discover Genes That Predict Good Response to Blood Cancer Therapy

  Samir Parekh

  16/06/22

  1 item of Media coverage

  Press/Media

• Researchers identify a signature of three genes linked to positive response to blood cancer therapy

  Samir Parekh

  16/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai to Lead Discussions on Transgender Health, Psychedelic Therapeutics and Long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival

  Marci Bowers, Brian Brown, Thomas Fuchs, Zahi Fayad, Joshua Safer, Rachel Yehuda, Helen Mayberg, & Kenneth L. Davis

  16/06/22

  15 items of Media coverage

  Press/Media

• Mount Sinai researchers discover genes that predict good response to blood cancer therapy

  Samir Parekh

  15/06/22 → 16/06/22

  3 items of Media coverage

  Press/Media

• Researchers discover genes that predict good response to blood cancer therapy

  Samir Parekh

  15/06/22

  4 items of Media coverage

  Press/Media

• No More ‘Flu For You

  Adolfo Garcia-Sastre,

  13/06/22

  1 item of Media coverage

  Press/Media

• New Discovery Blocks the Replication of Influenza Virus in Cells

  Adolfo Garcia-Sastre,

  1/06/22 → 2/06/22

  10 items of Media coverage

  Press/Media

• New Discovery Blocks Influenza Virus' Replication in Cells

  Adolfo Garcia-Sastre,

  1/06/22

  2 items of Media coverage

  Press/Media

• Blood Biomarker Predicts Crohn's Disease

  Sacha Gnjatic

  24/05/22 → 25/05/22

  7 items of Media coverage

  Press/Media

• News Antibody Detectable in Blood Predicts Complicated Crohn’s Disease An antibody detectable in blood can be used to predict severe Crohn’s disease and is detectable up to seven years prior to disease diagnosis.

  Sacha Gnjatic

  25/05/22

  3 items of Media coverage

  Press/Media

• Serological biomarker predicts severe Crohn's disease seven years prior to diagnosis

  Sacha Gnjatic

  24/05/22 → 25/05/22

  2 items of Media coverage

  Press/Media

• Blood Biomarker Predicts Complicated Crohn’s Disease Years before Diagnosis

  Sacha Gnjatic

  25/05/22

  1 item of Media coverage

  Press/Media

• Model Medicines Announces AI-Discovered Oral Antiviral Therapeutic, MDL-001, Has Demonstrated Potential Best-In-Class Combination Of Viral Load Reduction, Symptom Reduction, Activity Against SARS-CoV-2 Variants And Pan Antiviral Activity

  Kris White, & Adolfo Garcia-Sastre,

  20/05/22

  1 item of Media coverage

  Press/Media

• Model Medicines Announces AI-Discovered Oral Antiviral Therapeutic, MDL-001, Has Demonstrated Potential Best-In-Class Combination of Viral Load Reduction, Symptom Reduction, Activity Against SARS-CoV-2 Variants and Pan Antiviral Activity.

  Kris White, & Adolfo Garcia-Sastre,

  17/05/22

  35 items of Media coverage

  Press/Media

• AUA: Immunotherapy Aids Survival in Muscle-Invasive Bladder Cancer; Patients receiving nivolumab had an approximately 30 percent lower likelihood of developing cancer recurrence versus placebo.

  Matthew Galsky,

  17/05/22

  1 item of Media coverage

  Press/Media